menu search

Applied Therapeutics Reports First Quarter 2023 Financial Results

Applied Therapeutics Reports First Quarter 2023 Financial Results
Demonstrated Long-term Clinical Benefit of Govorestat in ACTION-Galactosemia Kids Trial Strengthened Balance Sheet with $30 Million Private Placement of Equity Phase 3 INSPIRE Trial of Govorestat in Sorbitol Dehydrogenase (SORD) Deficiency and ARISE-HF Trial of AT-001 in Diabetic Cardiomyopathy on Track for Data in 2023 NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) — Applied Therapeutics, […] The post Applied Therapeutics Reports First Quarter 2023 Financial Results appeared first on ForexTV... Read More
Posted: May 11 2023, 11:00
Author Name: forextv
Views: 081776

Search within

Pages Search Results: